US 9,808,491 B2
Compositions of morselized umbilical cord and/or amniotic membrane and methods of use thereof
Scheffer Tseng, Pinecrest, FL (US); and Lorraine Chua, Miami, FL (US)
Assigned to TISSUETECH, INC., Miami, FL (US)
Filed by TissueTech, Inc., Doral, FL (US)
Filed on Jun. 3, 2015, as Appl. No. 14/729,489.
Claims priority of provisional application 62/007,167, filed on Jun. 3, 2014.
Claims priority of provisional application 62/109,483, filed on Jan. 29, 2015.
Prior Publication US 2015/0342998 A1, Dec. 3, 2015
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 35/50 (2015.01); A61K 35/51 (2015.01); A61K 9/70 (2006.01); A61K 35/28 (2015.01); A61L 27/36 (2006.01); A61L 27/38 (2006.01); A61L 27/54 (2006.01); A61L 15/40 (2006.01); A61L 15/44 (2006.01)
CPC A61K 35/50 (2013.01) [A61K 9/7007 (2013.01); A61K 35/28 (2013.01); A61K 35/51 (2013.01); A61L 15/40 (2013.01); A61L 15/44 (2013.01); A61L 27/3604 (2013.01); A61L 27/38 (2013.01); A61L 27/54 (2013.01)] 31 Claims
 
1. A method for treating an ocular wound or repairing damaged ocular tissue in an individual in need thereof, comprising: administering to the individual a therapeutically effective amount of a gel composition comprising:
a) a therapeutically effective amount of i) morselized placental amniotic membrane and ii) morselized umbilical cord; and
b) a pharmaceutically-acceptable excipient;
wherein the morselized placental amniotic membrane and the morselized umbilical cord have a particle size of between about 0.1 mm to about 1.0 cm in length, width, and thickness.